Literature DB >> 10648091

Spontaneous regression of a large hepatocellular carcinoma with portal vein tumor thrombi: report of a case.

T Uenishi1, K Hirohashi, H Tanaka, T Ikebe, H Kinoshita.   

Abstract

A 65-year-old man with chronic hepatitis C showed a markedly elevated serum alpha-fetoprotein concentration. Computed tomography revealed a huge tumor occupying the entire right hepatic lobe. Three months later, the tumor regressed spontaneously from 12 cm to 7 cm in diameter without any medical treatment. A right hepatic lobectomy was performed 4 months after the initial diagnosis. The main tumor, located in the posterior inferior segment, was completely necrotic, and had a thick fibrous capsule. Many inflammatory cells had also infiltrated into the tumor. Only a small portion of a tumor thrombus in the portal vein and one of three intrahepatic metastases contained viable cancer cells. The tumor was found to be poorly differentiated hepatocellular carcinoma. Tumor regression may have been caused by a disturbance in hepatic circulation associated with the portal vein thrombus.

Entities:  

Mesh:

Year:  2000        PMID: 10648091     DOI: 10.1007/PL00010054

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  18 in total

1.  Spontaneous regression of lung adenocarcinoma: Report of a case.

Authors:  Tomohiro Haruki; Hiroshige Nakamura; Yuji Taniguchi; Ken Miwa; Yoshin Adachi; Shinji Fujioka; Kohei Shomori; Hisao Ito
Journal:  Surg Today       Date:  2010-11-26       Impact factor: 2.549

Review 2.  Spontaneous regression of hepatocellular carcinoma: three case reports and a categorized review of the literature.

Authors:  Susana Oquiñena; Mercedes Iñarrairaegui; Juan J Vila; Felix Alegre; Jose M Zozaya; Bruno Sangro
Journal:  Dig Dis Sci       Date:  2008-08-21       Impact factor: 3.199

Review 3.  Spontaneous regression of hepatocellular carcinoma: report of a case.

Authors:  Hiroshi Ohtani; Osamu Yamazaki; Mitsuharu Matsuyama; Katsuhiko Horii; Sadatoshi Shimizu; Hiroko Oka; Hiroko Nebiki; Kiyohide Kioka; Osamu Kurai; Yasuko Kawasaki; Takao Manabe; Katsuko Murata; Ryoichi Matsuo; Takeshi Inoue
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

4.  Spontaneous regression of hepatocellular carcinoma repeated 3 times with invasion of portal vein and inferior vena cava: report on a rare case.

Authors:  Hirokazu Komatsu; Satoshi Imamura; Tomoki Shimizu; Yuya Tsunoda; Tsuyoshi Ito; Jin Imai; Shuichi Nagakubo; Yuichi Morohoshi; Yuriko Fujita
Journal:  Clin J Gastroenterol       Date:  2011-12-09

Review 5.  Spontaneous regression of hepatocellular carcinoma is most often associated with tumour hypoxia or a systemic inflammatory response.

Authors:  Jonathan I Huz; Marcovalerio Melis; Umut Sarpel
Journal:  HPB (Oxford)       Date:  2012-05-15       Impact factor: 3.647

6.  Spontaneous regression of diffuse intrahepatic recurrence with portal vein tumor thrombus after resection of hepatocellular carcinoma.

Authors:  Akihiro Okano; Hiroshi Takakuwa; Takefumi Nakamura
Journal:  Clin J Gastroenterol       Date:  2010-12-14

7.  Spontaneous regression of a biopsy confirmed hepatocellular carcinoma.

Authors:  Neil Bhardwaj; Mo Li; Timothy Price; Guy J Maddern
Journal:  BMJ Case Rep       Date:  2014-07-21

Review 8.  HPV as a model for the development of prophylactic and therapeutic cancer vaccines.

Authors:  Raed N Samara; Samir N Khleif
Journal:  Curr Mol Med       Date:  2009-08       Impact factor: 2.222

9.  Management considerations for purported spontaneous regression of hepatocellular carcinoma: a case report.

Authors:  Takahide Sasaki; Daisuke Fukumori; Kentaroh Yamamoto; Fumio Yamamoto; Hirotsune Igimi; Yuichi Yamashita
Journal:  Case Rep Gastroenterol       Date:  2013-03-20

10.  Diagnostic biopsy does not commonly induce intratumoral CD8 T cell infiltration in Merkel cell carcinoma.

Authors:  Shinichi Koba; Kelly G Paulson; Kotaro Nagase; Andrew Tegeder; Renee Thibodeau; Jayasri G Iyer; Yutaka Narisawa; Paul Nghiem
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.